VIVS
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- VivoSim enters the Chinese market with its first commercial sales of NAMkind™ toxicology screening and efficacy testing servicesJul 21, 2026
- VivoSim presented data showing superior NAM liver toxicity prediction versus competing technologiesJun 29, 2026
- VivoSim released ADC data demonstrating its ability to detect toxicity and support safer antibody-drug conjugate designMar 24, 2026